/* Pinterest verifcation tag */

Latest News


MS Voice: June 2023

July 4, 2023 | MS Voice, Newsletter

Welcome to the June 2023 edition of MS Voice, your go-to e-Newsletter for the latest news, articles, and information on multiple sclerosis (MS) and the incredible work being done in the MS community. We have an exciting line up of topics to cover this month, so let’s dive right in!

Download MS Voice June 2023 here.

At MSNZ, your feedback and stories matter to us. We’ve been actively collating feedback, comments, and personal experiences from the MS community to include in our submission to Pharmac to fund Ocrelizumab. Your voices are instrumental in creating meaningful change, and we appreciate your contribution. Please continue to send your comments and stories to us.

Also in this edition, we were proud to share that MSNZ has been recognized with an international award! We are unbelievably thrilled about this.

Did you miss our recent webinar on aHSCT (autologous hematopoietic stem cell transplantation)? Don’t worry! We have you covered. The recording of the webinar is now available, allowing you to catch up on the valuable insights and information shared by experts in the field and NZ’s first recipient of aHSCT! Whether you’re considering aHSCT or simply interested in learning more, this recording is a must-watch.

Lastly, we encourage you to lend your support by adding your signature to the carers petition. This crucial initiative seeks to raise awareness about the invaluable role of caregivers in the lives of individuals living with MS. Join us in advocating for better recognition, resources, and support for these dedicated individuals who selflessly care for their loved ones.

Thank you for joining us in this edition of MS Voice. We hope you find the articles, information, and stories inspiring, informative, and empowering. Remember, together, we can make a difference in the lives of those affected by MS. Stay tuned for more updates and insights in our upcoming editions.

Download MS Voice June 2023 here.